-
EGTA for Reliable Calcium-Linked Viability Assays
2026-09-26
Learn how EGTA (SKU B7195) can help test whether extracellular calcium contributes to cell injury or viability changes, while avoiding common solubility and interpretation pitfalls. The guide separates product specifications from published calcium-channel findings and offers practical steps for controlled assay design.
-
Polyphyllin H Reverses Paclitaxel Resistance
2026-09-26
A 2025 study reports that Polyphyllin H binds membrane cholesterol, disrupts cholesterol-rich lipid rafts, and suppresses the drug-efflux transporters ABCB1 and ABCC3 in paclitaxel-resistant breast cancer models. The findings suggest a multi-transporter resistance strategy, while further work is needed to establish its safety and relevance in patients.
-
DNase I (RNase-free) for Clean RNA Workflows
2026-09-25
Remove DNA without sacrificing RNA quality in extraction, RT-PCR, and in vitro transcription workflows. Practical controls connect this sample-preparation step to a human sensory-neuron study while keeping the distinction clear: DNase cleanup supports molecular assays, not electrophysiology itself.
-
Rice Stripe Virus NS3 Rewires Host Kinase Signaling
2026-09-25
Zhuang et al. show that RSV NS3 shifts between distinct, infection-stage-dependent effects on rice kinase signaling, shaping antiviral defense, pathogenicity, and transmission. The work links NS3 phosphorylation and host ROS signaling to a proposed virus–plant–vector co-survival strategy, while highlighting the need to distinguish findings in plant virology from kinase studies in other systems.
-
Perifosine (KRX-0401): Assays and Workflows
2026-09-24
Perifosine offers a practical way to perturb Akt signaling in cancer-cell viability, apoptosis, and radiation-response experiments. This guide turns its reported activity into a controlled workflow—and distinguishes those oncology applications from the very different, early-stage stroke findings involving Akt/mTOR signaling.
-
Salvianolic Acid B, LH2, and Pulmonary Fibrosis
2026-09-24
The reference study connects elevated lysyl hydroxylase 2 (LH2) with collagen remodeling in pulmonary fibrosis and reports that Salvianolic acid B reduces LH2 expression alongside fibrotic features. Its value is a mechanism-led framework for testing collagen cross-linking, epithelial and fibroblast state changes, and Wnt/β-catenin signaling—not proof that the compound directly binds LH2 or is an established treatment.
-
SB525334 Workflows for TGF-beta1 Signaling
2026-09-23
Learn how to use SB525334 to isolate ALK5-dependent TGF-beta signaling in fibrosis, renal disease, and wound-healing assays. This practical guide connects Smad2/3 phosphorylation inhibition with the bone-transport findings reported in diabetic foot ulcer research.
-
Mechanism-Ready Western Blotting in Atherosclerosis
2026-09-22
A translational framework for connecting the octanal–Olfr2–calcium–ROS–NHE1 axis with more reproducible Western blot evidence, including strategic guidance on secondary antibody dilution, assay controls, and product selection.
-
HRP Rabbit Anti-Goat IgG (H+L) Workflow
2026-09-21
Build sensitive, reproducible assays for goat primary antibodies across western blot, ELISA, dot blot, and tissue imaging. This workflow connects localized p21 mRNA–LNP bladder cancer research with practical HRP-based validation strategies, including assay selection, optimization, and troubleshooting.
-
Ibrexafungerp Workflows for Resistant Candida
2026-09-21
Ibrexafungerp enables research workflows that connect glucan-synthase inhibition with resistant Candida profiling, acidic-pH testing, and translational infection models. Its distinct binding behavior from echinocandins makes MK 3118 especially useful for mapping genotype–phenotype relationships rather than assuming universal cross-resistance.
-
Defactinib: FAK Biology for Translational Research
2026-09-20
A mechanistic and strategic guide to using Defactinib as a FAK phosphorylation inhibitor, linking FAK Tyr397 biology, ovarian cancer research, paclitaxel combinations, and phosphoproteomic thinking without overstating cross-domain evidence.
-
Salvianolic acid B: LH2 Assay Workflow
2026-09-19
Build a matrix-first pulmonary fibrosis workflow around Salvianolic acid B, connecting LH2 expression with collagen remodeling, EMT, and fibroblast activation. Practical handling guidance, orthogonal readouts, and troubleshooting steps help distinguish a genuine antifibrotic response from formulation, viability, or assay-interference artifacts.
-
Erlotinib (NSC 718781) EGFR Assay Workflows
2026-09-19
Use Erlotinib (NSC 718781) to connect EGFR kinase inhibition with phospho-signaling, proliferation, and apoptosis outcomes. This workflow also shows how to position the compound alongside NanoBRET and proximity ligation assays when receptor crosstalk, including CXCR4–EGFR signaling, is the biological question.
-
FGFR1 as a Druggable Target in Schizophrenia
2026-09-18
The reference study integrates drug-target Mendelian randomization, colocalization, SMR validation, phenome-wide association analysis, molecular docking, and single-cell expression data to identify schizophrenia-relevant therapeutic targets. FGFR1 emerged as the most promising candidate, although the findings remain a genetically informed and computationally supported basis for validation rather than evidence of clinical efficacy.
-
Phytol as a Translational RXR Signaling Tool
2026-09-18
Phytol is more than a catalog reagent: it is a context-sensitive probe for retinoid X receptor signaling, PPARα-linked metabolism, and GABAergic transmission modulation. This thought-leadership guide connects mechanistic assay design with translational strategy while using polymer self-assembly research to illustrate why controlled composition, solvent, and identity variables matter.